Works matching AU Seino, Yutaka
Results: 222
Pathogenesis of type 2 diabetes in Japan and East Asian populations: Basic and clinical explorations.
- Published in:
- Proceedings of the Japan Academy, Series B Physical & biological sciences, 2025, v. 101, n. 2, p. 68, doi. 10.2183/pjab.101.009
- By:
- Publication type:
- Article
Dietary Protein Intake Is a Determining Factor for Skeletal Muscle Mass in Japanese Older People with Type 2 Diabetes: A Cross-Sectional Study.
- Published in:
- Nutrients, 2025, v. 17, n. 4, p. 731, doi. 10.3390/nu17040731
- By:
- Publication type:
- Article
Sequence of Eating at Japanese-Style Set Meals Improves Postprandial Glycemic Elevation in Healthy People.
- Published in:
- Nutrients, 2025, v. 17, n. 4, p. 658, doi. 10.3390/nu17040658
- By:
- Publication type:
- Article
Gender Difference in ICER Iγ Transgenic Diabetic Mouse.
- Published in:
- Bioscience, Biotechnology & Biochemistry, 2007, v. 71, n. 8, p. 1920, doi. 10.1271/bbb.70116
- By:
- Publication type:
- Article
Self-monitoring of blood glucose (SMBG) improves glycaemic control in oral hypoglycaemic agent (OHA)-treated type 2 diabetes (SMBG-OHA study).
- Published in:
- Diabetes/Metabolism Research & Reviews, 2013, v. 29, n. 1, p. 77, doi. 10.1002/dmrr.2363
- By:
- Publication type:
- Article
Insulin Secretory Defect and Insulin Resistance in Isolated Impaired Fasting Glucose and Isolated Impaired Glucose Tolerance.
- Published in:
- Journal of Diabetes Research, 2015, p. 1, doi. 10.1155/2016/1298601
- By:
- Publication type:
- Article
The Ulaanbaatar agreement: Revising diabetes terminology in Asia to combat stigma.
- Published in:
- Journal of Diabetes Investigation, 2024, v. 15, n. 11, p. 1533, doi. 10.1111/jdi.14330
- By:
- Publication type:
- Article
Safety and effectiveness of tofogliflozin in Japanese people with type 2 diabetes: A multicenter prospective observational study in routine clinical practice.
- Published in:
- Journal of Diabetes Investigation, 2024, v. 15, n. 11, p. 1585, doi. 10.1111/jdi.14287
- By:
- Publication type:
- Article
Long‐term safety and efficacy of SGLT2 inhibitor use in older east Asians with type 2 diabetes.
- Published in:
- Journal of Diabetes Investigation, 2024, v. 15, n. 1, p. 63, doi. 10.1111/jdi.14097
- By:
- Publication type:
- Article
Is caloric restriction enough to increase longevity? Fasting and circadian alignment.
- Published in:
- Journal of Diabetes Investigation, 2023, v. 14, n. 8, p. 933, doi. 10.1111/jdi.14033
- By:
- Publication type:
- Article
Empagliflozin is associated with lower risk of cardiovascular events and all‐cause mortality in routine care in East Asia: Results from the EMPRISE study.
- Published in:
- Journal of Diabetes Investigation, 2023, v. 14, n. 3, p. 417, doi. 10.1111/jdi.13959
- By:
- Publication type:
- Article
Association of dipeptidyl peptidase‐4 inhibitor use and risk of pancreatic cancer in individuals with diabetes in Japan.
- Published in:
- Journal of Diabetes Investigation, 2023, v. 14, n. 1, p. 67, doi. 10.1111/jdi.13921
- By:
- Publication type:
- Article
Stigma evaluation for diabetes and other chronic non‐communicable disease patients: Development, validation and clinical use of stigma scale – The Kanden Institute Stigma Scale.
- Published in:
- Journal of Diabetes Investigation, 2022, v. 13, n. 12, p. 2081, doi. 10.1111/jdi.13894
- By:
- Publication type:
- Article
A randomized trial to investigate the efficacy and safety of once‐daily liraglutide 1.8 mg in Japanese adults with type 2 diabetes exhibiting an inadequate response to liraglutide 0.9 mg.
- Published in:
- Journal of Diabetes Investigation, 2022, v. 13, n. 8, p. 1321, doi. 10.1111/jdi.13789
- By:
- Publication type:
- Article
Efficacy and safety of once‐weekly semaglutide in Japanese individuals with type 2 diabetes by baseline age and body mass index.
- Published in:
- Journal of Diabetes Investigation, 2022, v. 13, n. 7, p. 1161, doi. 10.1111/jdi.13773
- By:
- Publication type:
- Article
Healthcare resource utilization in patients treated with empagliflozin in East Asia.
- Published in:
- Journal of Diabetes Investigation, 2022, v. 13, n. 5, p. 810, doi. 10.1111/jdi.13728
- By:
- Publication type:
- Article
Effects of physician's diabetes self‐management education using Japan Association of Diabetes Education and Care Diabetes Education Card System Program and a self‐monitoring of blood glucose readings analyzer in individuals with type 2 diabetes: An exploratory, open‐labeled, prospective randomized clinical trial
- Published in:
- Journal of Diabetes Investigation, 2021, v. 12, n. 12, p. 2221, doi. 10.1111/jdi.13607
- By:
- Publication type:
- Article
Effects of glucagon‐like peptide‐1 receptor agonists on secretions of insulin and glucagon and gastric emptying in Japanese individuals with type 2 diabetes: A prospective, observational study.
- Published in:
- Journal of Diabetes Investigation, 2021, v. 12, n. 12, p. 2162, doi. 10.1111/jdi.13598
- By:
- Publication type:
- Article
A novel RFX6 heterozygous mutation (p.R652X) in maturity‐onset diabetes mellitus: A case report.
- Published in:
- 2021
- By:
- Publication type:
- Case Study
Lifestyle changes as a result of COVID‐19 containment measures: Bodyweight and glycemic control in patients with diabetes in the Japanese declaration of a state of emergency.
- Published in:
- Journal of Diabetes Investigation, 2021, v. 12, n. 9, p. 1718, doi. 10.1111/jdi.13526
- By:
- Publication type:
- Article
Glutamate is an essential mediator in glutamine‐amplified insulin secretion.
- Published in:
- Journal of Diabetes Investigation, 2021, v. 12, n. 6, p. 920, doi. 10.1111/jdi.13497
- By:
- Publication type:
- Article
The Asian Association for the Study of Diabetes: The first 10 years and the next 10 years.
- Published in:
- Journal of Diabetes Investigation, 2020, v. 11, n. 5, p. 1079, doi. 10.1111/jdi.13353
- By:
- Publication type:
- Article
The journey to understanding incretin systems: Theory, practice and more theory.
- Published in:
- Journal of Diabetes Investigation, 2019, v. 10, n. 5, p. 1171, doi. 10.1111/jdi.13123
- By:
- Publication type:
- Article
Twincretin as a potential therapeutic for the management of type 2 diabetes with obesity.
- Published in:
- Journal of Diabetes Investigation, 2019, v. 10, n. 4, p. 902, doi. 10.1111/jdi.13005
- By:
- Publication type:
- Article
Actual condition survey regarding mismatch of measurements between radioimmunoassay and enzyme‐linked immunosorbent assay tests for anti‐glutamic acid decarboxylase antibody in real‐world clinical practice.
- Published in:
- Journal of Diabetes Investigation, 2019, v. 10, n. 3, p. 685, doi. 10.1111/jdi.12955
- By:
- Publication type:
- Article
Safety and tolerability of empagliflozin in East Asian patients with type 2 diabetes: Pooled analysis of phase I–III clinical trials.
- Published in:
- Journal of Diabetes Investigation, 2019, v. 10, n. 2, p. 418, doi. 10.1111/jdi.12910
- By:
- Publication type:
- Article
Solid‐phase extraction treatment is required for measurement of active glucagon‐like peptide‐1 by enzyme‐linked immunosorbent assay kit affected by heterophilic antibodies.
- Published in:
- Journal of Diabetes Investigation, 2019, v. 10, n. 2, p. 302, doi. 10.1111/jdi.12896
- By:
- Publication type:
- Article
Mental distress and health‐related quality of life among type 1 and type 2 diabetes patients using self‐monitoring of blood glucose: A cross‐sectional questionnaire study in Japan.
- Published in:
- Journal of Diabetes Investigation, 2018, v. 9, n. 5, p. 1203, doi. 10.1111/jdi.12827
- By:
- Publication type:
- Article
Relationship between deterioration of glycated hemoglobin‐lowering effects in dipeptidyl peptidase‐4 inhibitor monotherapy and dietary habits: Retrospective analysis of Japanese individuals with type 2 diabetes.
- Published in:
- Journal of Diabetes Investigation, 2018, v. 9, n. 5, p. 1153, doi. 10.1111/jdi.12779
- By:
- Publication type:
- Article
Reply to the comment of Wilbrink et al. on Retrospective analysis of liraglutide and basal insulin combination therapy in Japanese type 2 diabetes: The association between remaining β‐cell function and the achievement of the HbA1c target 1 year after initiation
- Published in:
- Journal of Diabetes Investigation, 2018, v. 9, n. 4, p. 981, doi. 10.1111/jdi.12858
- By:
- Publication type:
- Article
Efficacy and safety of adding liraglutide to existing insulin regimens in Japanese patients with type 2 diabetes mellitus: A post‐hoc analysis of a phase 3 randomized clinical trial.
- Published in:
- Journal of Diabetes Investigation, 2018, v. 9, n. 4, p. 840, doi. 10.1111/jdi.12793
- By:
- Publication type:
- Article
Retrospective analysis of liraglutide and basal insulin combination therapy in Japanese type 2 diabetes patients: The association between remaining β‐cell function and the achievement of the glycated hemoglobin target 1 year after initiation.
- Published in:
- Journal of Diabetes Investigation, 2018, v. 9, n. 4, p. 822, doi. 10.1111/jdi.12773
- By:
- Publication type:
- Article
Safety and efficacy of the combination of the glucagon‐like peptide‐1 receptor agonist liraglutide with an oral antidiabetic drug in Japanese patients with type 2 diabetes: Post‐hoc analysis of a randomized, 52‐week, open‐label, parallel‐group trial
- Published in:
- Journal of Diabetes Investigation, 2018, v. 9, n. 4, p. 831, doi. 10.1111/jdi.12759
- By:
- Publication type:
- Article
Weekly glucagon‐like peptide‐1 receptor agonist albiglutide as monotherapy improves glycemic parameters in Japanese patients with type 2 diabetes mellitus: A randomized, double‐blind, placebo‐controlled study.
- Published in:
- Journal of Diabetes Investigation, 2018, v. 9, n. 3, p. 558, doi. 10.1111/jdi.12749
- By:
- Publication type:
- Article
Changes in heart rate in patients with type 2 diabetes mellitus after treatment with luseogliflozin: Subanalysis of placebo‐controlled, double‐blind clinical trials.
- Published in:
- Journal of Diabetes Investigation, 2018, v. 9, n. 3, p. 638, doi. 10.1111/jdi.12726
- By:
- Publication type:
- Article
Sodium‐glucose cotransporter‐2 inhibitor luseogliflozin added to glucagon‐like peptide 1 receptor agonist liraglutide improves glycemic control with bodyweight and fat mass reductions in Japanese patients with type 2 diabetes: A 52‐week, open‐label, single‐arm study
- Published in:
- Journal of Diabetes Investigation, 2018, v. 9, n. 2, p. 332, doi. 10.1111/jdi.12694
- By:
- Publication type:
- Article
Safety, tolerability and efficacy of lixisenatide as monotherapy in Japanese patients with type 2 diabetes mellitus: An open-label, multicenter study.
- Published in:
- Journal of Diabetes Investigation, 2018, v. 9, n. 1, p. 108, doi. 10.1111/jdi.12646
- By:
- Publication type:
- Article
Incretin concept revised: The origin of the insulinotropic function of glucagon-like peptide-1 - the gut, the islets or both?
- Published in:
- Journal of Diabetes Investigation, 2018, v. 9, n. 1, p. 21, doi. 10.1111/jdi.12718
- By:
- Publication type:
- Article
Safety, tolerability and efficacy of lixisenatide in combination with oral antidiabetic treatment in Japanese patients with type 2 diabetes: An open-label, multicenter study.
- Published in:
- Journal of Diabetes Investigation, 2018, v. 9, n. 1, p. 127, doi. 10.1111/jdi.12686
- By:
- Publication type:
- Article
Evaluation of large-scale clinical trials on cardiovascular disease risk in patients with type 2 diabetes mellitus treated with dipeptidyl peptidase 4 inhibitors and a new class of drugs.
- Published in:
- 2017
- By:
- Publication type:
- Editorial
Cardiovascular safety trials of incretin-based drugs: What do they mean?
- Published in:
- Journal of Diabetes Investigation, 2017, v. 8, n. 3, p. 272, doi. 10.1111/jdi.12576
- By:
- Publication type:
- Article
Combination therapy with liraglutide and insulin in Japanese patients with type 2 diabetes: A 36-week, randomized, double-blind, parallel-group trial.
- Published in:
- Journal of Diabetes Investigation, 2016, v. 7, n. 4, p. 565, doi. 10.1111/jdi.12457
- By:
- Publication type:
- Article
Incretin-based drugs for type 2 diabetes: Focus on East Asian perspectives.
- Published in:
- Journal of Diabetes Investigation, 2016, v. 7, p. 102, doi. 10.1111/jdi.12490
- By:
- Publication type:
- Article
Liraglutide is effective and well tolerated in combination with an oral antidiabetic drug in Japanese patients with type 2 diabetes: A randomized, 52-week, open-label, parallelgroup trial.
- Published in:
- Journal of Diabetes Investigation, 2016, v. 7, n. 1, p. 76, doi. 10.1111/jdi.12367
- By:
- Publication type:
- Article
Efficacy and safety of luseogliflozin added to various oral antidiabetic drugs in Japanese patients with type 2 diabetes mellitus.
- Published in:
- Journal of Diabetes Investigation, 2015, v. 6, n. 4, p. 443, doi. 10.1111/jdi.12316
- By:
- Publication type:
- Article
Efficacy and safety of lixisenatide in Japanese patients with type 2 diabetes mellitus inadequately controlled by sulfonylurea with or without metformin: Subanalysis of Get Goal- S.
- Published in:
- Journal of Diabetes Investigation, 2015, v. 6, n. 2, p. 201, doi. 10.1111/jdi.12275
- By:
- Publication type:
- Article
Relationship and factors responsible for regulating fasting and post-challenge plasma glucose levels in the early stage development of type 2 diabetes mellitus.
- Published in:
- Journal of Diabetes Investigation, 2014, v. 5, n. 6, p. 663, doi. 10.1111/jdi.12239
- By:
- Publication type:
- Article
Dipeptidyl peptidase-4 inhibitors and sulfonylureas for type 2 diabetes: Friend or foe?
- Published in:
- 2014
- By:
- Publication type:
- Editorial
Factors influencing the durability of the glucose-lowering effect of sitagliptin combined with a sulfonylurea.
- Published in:
- Journal of Diabetes Investigation, 2014, v. 5, n. 4, p. 445, doi. 10.1111/jdi.12182
- By:
- Publication type:
- Article
Sensory and motor physiological functions are impaired in gastric inhibitory polypeptide receptor-deficient mice.
- Published in:
- Journal of Diabetes Investigation, 2014, v. 5, n. 1, p. 31, doi. 10.1111/jdi.12129
- By:
- Publication type:
- Article